Page last updated: 2024-08-25

mesulergine and Hyperprolactinaemia

mesulergine has been researched along with Hyperprolactinaemia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (66.67)	18.7374
1990's	2 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pawlikowski, M; Pisarek, H; Stepien, H	1
Pisarek, H; Stepien, H	1
Crosignani, PG; Ferrari, C	1
Chang, RJ; Goodman, LA; Hesla, JS; Molitch, ME; Rodman, EF	1
Buvat, J; Dewailly, D; Fossati, P; Fourlinnie, JC; Lemaitre, G; Mazzuca, M; Thomas, P; Wemeau, JL	1
Brabant, G; Brennecke, I; Friedrich, H; Herrmann, H; Hesch, RD; von zur Mühlen, A; Wagner, TO	1

Reviews

1 review(s) available for mesulergine and Hyperprolactinaemia

Article	Year
Medical treatment of hyperprolactinaemic disorders. Human reproduction (Oxford, England), 1986, Volume: 1, Issue:8 Topics: Acromegaly; Bromocriptine; Delayed-Action Preparations; Dopamine; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Psychoses, Substance-Induced; Tamoxifen	1986

Trials

1 trial(s) available for mesulergine and Hyperprolactinaemia

Article	Year
Treatment of human hyperprolactinaemia with a new dopamine agonist: CU 32085 (mesulergin). Acta endocrinologica, 1985, Volume: 110, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Gonads; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Tomography, X-Ray Computed	1985

Article

Year

Treatment of human hyperprolactinaemia with a new dopamine agonist: CU 32085 (mesulergin).

Acta endocrinologica, 1985, Volume: 110, Issue:4

Topics: Administration, Oral; Adolescent; Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Gonads; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Tomography, X-Ray Computed

1985

Other Studies

4 other study(ies) available for mesulergine and Hyperprolactinaemia

Article	Year
Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary. Endocrine regulations, 1992, Volume: 26, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Diethylstilbestrol; Dose-Response Relationship, Drug; Ergolines; Female; Hyperplasia; Hyperprolactinemia; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2; Spiperone; Time Factors; Tritium	1992
The effect of mesulergine on prolactin secretion and anterior pituitary cells morphology in diethylstilboestrol-treated female Wistar rats. Histology and histopathology, 1992, Volume: 7, Issue:1 Topics: Animals; Antiparkinson Agents; Bromocriptine; Cell Division; Diethylstilbestrol; Drug Interactions; Ergolines; Female; Hyperprolactinemia; Immunohistochemistry; Pergolide; Pituitary Gland, Anterior; Prolactin; Rats	1992
The effect of the ergoline derivative, CU 32-085, on prolactin secretion in hyperprolactinemic women. Fertility and sterility, 1987, Volume: 48, Issue:4 Topics: Adenoma; Adult; Ergolines; Female; Humans; Hyperprolactinemia; Kinetics; Menstruation Disturbances; Pituitary Neoplasms; Prolactin	1987
[Hyperprolactinemia and prolactinomas. Results of surgical and drug therapy]. Deutsche medizinische Wochenschrift (1946), 1985, Oct-11, Volume: 110, Issue:41 Topics: Adolescent; Adult; Aged; Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Lisuride; Male; Middle Aged; Paraneoplastic Endocrine Syndromes; Prolactin	1985